Resultado da Busca
11 de jun. de 2024 · Alguns marcadores tumorais conhecidos são CA 125, para câncer de ovário; CA 19.9 para câncer de pâncreas, fígado ou câncer colorretal; e CEA, para câncer colorretal e de tireoide, por exemplo.
17 de jun. de 2024 · O CA19-9 é indicado no auxílio ao estadiamento e monitoramento no tratamento em primeira escolha de câncer de pâncreas e trato biliar e, em segunda escolha no câncer colo retal. É obtida maior sensibilidade diagnóstica quando um teste para CA 19-9 é combinado com análise de imagem, como ultrassonografia ou tomografia.
16 de jun. de 2024 · CA 19-9 is an extremely useful biomarker for pancreatic ductal adenocarcinomas (PDACs). However, the optimal cut-off and prognostic significance at higher cut-offs are yet to be determined. Methods. Retrospective analysis included patients with PDAC who underwent curative resection from January 2010 to May 2020 at Tata Memorial Centre, Mumbai.
26 de jun. de 2024 · Cancer antigen 19-9 (CA19.9) is a carbohydrate antigen that is often elevated in the blood of patients with certain types of cancers, such as pancreatic cancer, colorectal cancer, and gastric cancer. It is one of the most widely used tumor markers for these diseases.
13 de jun. de 2024 · Conventional tumor markers may serve as adjuncts in non-small cell lung cancer (NSCLC) management. This study analyzed whether three tumor markers (CEA, CA19-9, and CA-125) held associations with radiographic and clinical outcomes in NSCLC.
Since surgery, CA 19-9 is now almost 3000, the highest value ever. Recent CT scan showed no evidence of metastases and no evidence of recurrence. Can anyone help me understand what could be going on?
19 de jun. de 2024 · “The aim of this retrospective study was to provide additional evidence for the clinical use of conventional serum tumor markers CEA, CA19-9, and CA-125 in NSCLC management.” It constituted a single-center study of NSCLC patients treated with systemic therapy at the London Regional Cancer Program.
